|
05.02.2024 10:36:07
|
Biotech High-Flyers That Just Hit 52-Week Highs
(RTTNews) - In the biotech investment landscape, staying ahead of the curve is key to unlocking potential gains. The following biotech stocks, featured on our site, hit 52-week highs recently. Please note that the list is not exhaustive, and it represents merely a fraction of the high-performing stocks we have profiled.
*Last Closing Price refers to the stock's closing price on Feb.2, 2024.
Ticker | Published Date | Published Price | Maximum Price Since Publication | *Last Closing Price | Maximum Gain % |
|---|---|---|---|---|---|
May 26, 2023 | $9.54 | $18.10 | $17.75 | 89% | |
Oct.16, 2023 | $6.71 | $19.50 | $18.55 | 1.9 | |
Jan.22, 2024 | $15.52 | $39.62 | $39.15 | 155% | |
Mar.3, 2023 | $7.97 | $28.44 | $27.69 | 256% | |
Jan.2, 2024 | $12.53 | $16.88 | $15.22 | 35% | |
Aug.1, 2023 | $12.35 | $29.42 | $28.70 | 138% | |
Jul.10, 2023 | $31.30 | $50.20 | $47.24 | 60% | |
Nov.29, 2023 | $16.56 | $29.68 | $28.54 | 79% | |
Dec.19, 2023 | $11.22 | $14.76 | $14.59 | 31% | |
June 5, 2023 | $24.71 | $45 | $44.33 | 82% | |
Oct.31, 2023 | $8.75 | $14.49 | $14.26 | 65% | |
Dec.15, 2023 | $121.17 | $143.76 | $139.77 | 18% | |
Jan.25, 2024 | $2.57 | $3.90 | $3.52 | 51% | |
Nov.21, 2023 | $8.95 | $16.10 | $15.70 | 79% | |
Sep.15, 2023 | $4.99 | $14.07 | $14.00 | 182% | |
Sep.11, 2023 | $3.55 | $4.84 | $4.60 | 36% | |
Nov.28, 2023 | $23 | $47.11 | $46.15 | 105% | |
June 6, 2023 | $7.04 | $11.80 | $11.07 | 67% |
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Y-mAbs Therapeutics Inc Registered Shsmehr Nachrichten
|
07.11.24 |
Ausblick: Y-mAbs Therapeutics stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net) | |
|
11.08.24 |
Ausblick: Y-mAbs Therapeutics gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net) |
Analysen zu Y-mAbs Therapeutics Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
| Alvotech Registered Shs | 11,30 | -1,31% |
|
| Ascendis Pharma (spons. ADRs) | 115,00 | 0,88% |
|
| Cullinan Management Inc Registered Shs | 13,10 | -2,60% |
|
| Edgewise Therapeutics Inc Registered Shs | 31,51 | 2,34% |
|
| IDEAYA Biosciences Inc Registered Shs | 24,20 | -1,63% |
|
| Ironwood Pharmaceuticals Inc (A) | 3,68 | -4,17% |
|
| KalVista Pharmaceuticals Inc | 8,65 | -2,81% |
|
| Morphosys AG (spons. ADRs) | 16,70 | 3,73% |
|
| Relmada Therapeutics Inc Registered Shs | 2,80 | -0,71% |
|
| RxSight Inc Registered Shs | 45,12 | 1,03% |
|
| SpringWorks Therapeutics Inc Registered Shs | 37,93 | 9,75% |
|
| Spruce Biosciences Inc Registered Shs | 0,49 | 2,60% |
|
| Tarsus Pharmaceuticals Inc Registered Shs | 46,89 | 5,06% |
|
| Vera Therapeutics Inc Registered Shs -A- | 45,90 | 2,43% |
|
| Y-mAbs Therapeutics Inc Registered Shs | 10,86 | 1,31% |
|
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.